Immunological analysis in paediatric HIV patients at different stages of the disease

Scandinavian Journal of Immunology

Volumn 60, Issue 6, 2004, Pages 615-624

  Lian, Y C ^a   Della Negra, M ^a   Rutz, R ^b   Ferriani, V ^c   De Moraes Vasconcelos, D ^c   Da Silva Duarte, A J ^c   Kirschfink, M ^b   Grumach, A S ^c  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; MANNAN BINDING LECTIN;

ALLOTYPE; ANEMIA; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CANDIDIASIS; CHILD; CHILDHOOD CANCER; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; OPPORTUNISTIC INFECTION; PEDIATRICS; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SEPSIS;

ANTIBODIES; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFANT; MALE; MANNOSE-BINDING LECTIN;

EID: 10844237297     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01492.x     Document Type: Article

References (49)

1. Scott GB, Buck BE, Leterman JG, Bloom FL, Parks WP. Acquired immunodeficiency syndrome in infants. N Engl J Med 1984;310:76-81.
2. Ebrahim SH, Peterman TA, Zaidi AA, Hamers FF. Geography of AIDS associated Kaposi's Sarcoma in Europe. AIDS 1997;11:1739-45.
3. Nicholas SW. Guidelines for the care of children and adolescent with HIV infection. Management of the HIV-positive child with fever. J Pediatr 1991;119:21-4.
4. Dierich MP, Ebenbichler CF, Marschang P, Fust G, Thielens NM, Arlaud GJ. HIV and human complement. Mechanisms of interaction and biological implication. Immunol Today 1993;14:435-40.
5. Marschang P, Ebenbichler CF, Dierich MP. HIV and complement role of the complement system in HIV infection. Int Arch Allergy Immunol 1994;103:113-7.
6. Haurum JS, Thiel S, Jones LM, Fischer PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307-13.
7. Stoiber H, Clivio A, Dierich MP. Role of complement in HIV infection. Annu Rev Immunol 1997;15:649-74.
8. Bishof NA, Welch TR, Beischel LS. C4B deficiency: a risk factor for bacteremia with encapsulated organisms. J Infect Dis 1990;162:248-50.
9. Hentges F, Hoffman A, Oliveira De Araujo F, Hemmer R. Prolonged clinical asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC. Clin Exp Immunol 1992;88:237-42.
10. Cameron PU, Cobain TJ, Zhang WJ, Kay PH, Dawkins RL. Influence of C4 null genes on infection with human immunodeficiency virus. BMJ 1988;296:1627-8.
11. Bouhlal H, Chomont N, Haeffner-Cavaillon N, Kazatchkine MD, Belec L, Hocini H. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J Immunol 2002;169(6):3301-6.
12. Caldwell MB, Oxtoby MJ, Simonds RJ et al. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-19.
13. Erkeller-Yuksel FM, Deneys V, Yuksel B et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-22.
14. Fujimura MD. Niveis Séricos das Subclasses de Imunoglobulina G em Crianças Normais e Nefróticas. Doctoral Thesis. São Paulo: University of São Paulo Medical School, 1990: 159.
15. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM eds. Experimental Immunochemistry, 2nd edn. Springfield: Thomas, 1991: 133-240.
16. Ferriani VPL, Barbosa JE, Carvalho IF. Complement haemolytic activity (classical and alternative pathways), C3, C4 and factor B titres in healthy children. Acta Paediatr 1999;88:1062-6.
17. Brandslund J, Sierted HC, Svehag SE, Teisner B. Double decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods 1981;44:64-71.
18. Chrispeels J, Bank S, Rittner C, Bitter-Suermann D. Sandwich enzyme-linked immunosorbent assays for the quantification of the CD4 isotypes (C4A and C4B) in human plasma. J Immunol Methods 1989;125:5-12.20.
19. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human Plasma increases during an acute phase response. Clin Exp Immunol 1992;90:31-5.
20. Vermelho LL, Silva LP, Costa AJL. Epidemiologia da Transmissão Vertical do HIV no Brasil, National Coordenation of STD/AIDS, Minister of Health, Brasilia. [Retrieved from http://www.aids. gov.br/udtv/boledm_jun_ago99/ trans_vertical.htm]
21. Rosenberg ZF, Fauci AS. Immunopathogenesis of HIV infection. FASEB J 1991;5:2382-90.
22. Pizzo PA, Wilfert CM. Markers and determinants of disease progression in children with HIV infection. J Acquit Immune Defic Syndr Hum Retrovirol 1995;8:30-44.
23. Moss WJ, Dedyo T, Suarez M, Nicholas SW, Abtams E. Tuberculosis in children infected with human immunodeficiency virus a report of five cases. Pediatr Infect Dis J 1992;11:114-6.
24. Lewis LL, Butler KM, Husson RN et al. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellular infection. J Pediatr 1993;121:677-83.
25. Lipshultz SE, Easley KA, Orav EJ et al. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV infection (P(2)C(2) HIV) Study Group. Lancet 2002;360 (9330):368-73.
26. Marks MJ, Haney PJ, Mcdermott MP, White CS, Vennos AD. Thoracic disease in children widi AIDS. Radiographics 1996;16:1349-62.
27. Mofenson LM, Korelitz J, Meyer WA III et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV 1 infected children. J Infect Dis 1997;175:1029-38.
28. Chirmule N, Lesser M, Gupta A, Ravipati M, Kohn N, Pahwa S. Immunological characteristics of HIV-infected children: relationship to age, CD4 counts, disease progression, and survival. AIDS Res Hum Retroviruses 1995;11:1209-19.
29. Pahwa S. Immune defects in pediatric AIDS, their pathogenesis, and role of immunotherapy. Crit Care Med 1990;18:S138-43.
30. Schuval SJ, Bonagura VR, Ilowite NT. Rheumatologic manifestations of pediatric human immunodeficiency virus infection. J Rheumatol 1993;20:1578-82.
31. Simpson BJ, Andiman WA. Difficulties in assigning human immunodeficiency virus-1 infection and setotevetsion status in a cohort of HIV-exposed children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics 1994;93:840-2.
32. Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 1993;7:975-80.
33. Shearer WT, Easley KA, Goldfarb J et al. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann N Y Acad Sci 2000;918:298-312.
34. Stoiber H, Speth C, Dierich MP. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 2003;21 (S2):77-82.
35. Stoiber H, Pinter C, Siccardi AG, Clivio A, Dierich MP. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 1996;183:307-10.
36. Perricone R, Fontana L, De Carolis C, Carini C, Sirianni MC, Aiuti F. Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol 1987: 70, 500-7.
37. Jarvis JN, Taylor H, Iobidze M, Dejange J, Chang S, Cohen F. Rheumatoid factor expression and complement activation in children congenitally infected with human immunodeficiency virus. Clin Immunol Immunopathol 1993;67:50-4.
38. Jarvis JN, Taylor H, Iobidze M. Complement activation and immune complexes in early congenital HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:480-5.
39. Fust G, Ujhelyi E, Hidvégi T et al. The complement system in HIV disease. Immunol Invest 1991;20:231-41.
40. Senaldi G, Peakman MI, McManus T, Davies ET, Tee DEH, Vergani D. Activation of the complement system in human immunodeficiency virus infection relevance of the classical pathway to pathogenesis and disease severity. J Infect Dis 1990;62: 1227-32.
41. Senaldi G, Davies ET, Mahalingam M et al. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect 1995;31:145-8.
42. Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel S. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin Exp Immunol 1995;100:219-22.
43. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995;346:941-3.
44. Prohászka Z, Nemes J, Hidvégi T et al. Two parallel routes of the complement mediated antibody-dependent enhancement of HIV-1 infection. AIDS 1997;11:949-58.
45. Hentges F, Hoffman A, Oliveira-de-Araujo F, Hemmer R. Prolonged clinical asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC. Clin Exp Immunol 1992;88:237-42.
46. Just JJ, Abrams E, Loule LG et al. Influence of host genotype on progression to acquired immunodeficiency virus type 1. J Pediatr 1995;127:544-9.
47. Goddard EA, Creemers P, Beatty DW. C4B isotype deficiency in Haemophilus influenzae type b and meningococcal meningitis. Pediatr Infect Dis J 1994;13:661-2.
48. Rowe PC, McLean RH, Wood RA, Leggiadro RJ, Winkelstein JA. Association of homozygous C4B deficiency with bacterial meningitis. J Infect Dis 1989;160:448-51.
49. Quinn TC, Ruff A, Halsey N. Pediatric acquired immunodeficiency syndrome: special considerations for developing nations. Pediatr Infect Dis J 1992;11:558-68.